相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
Daniel Sanghoon Shin et al.
CANCER DISCOVERY (2017)
Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer
Svasti Haricharan et al.
CANCER DISCOVERY (2017)
Extracting replicable associations across multiple studies: Empirical Bayes algorithms for controlling the false discovery rate
David Amar et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer
Cynthia X. Ma et al.
CLINICAL CANCER RESEARCH (2017)
A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer
Cynthia X. Ma et al.
CLINICAL CANCER RESEARCH (2016)
GenVisR: Genomic Visualizations in R
Zachary L. Skidmore et al.
BIOINFORMATICS (2016)
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek et al.
NATURE (2016)
Exploring genomic alteration in pediatric cancer using ProteinPaint
Xin Zhou et al.
NATURE GENETICS (2016)
DoCM: a database of curated mutations in cancer
Benjamin J. Ainscough et al.
NATURE METHODS (2016)
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
Jesse M. Zaretsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML
K. Krysiak et al.
BLOOD CANCER JOURNAL (2016)
Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas
Obi L. Griffith et al.
CELL REPORTS (2016)
Genome Modeling System: A Knowledge Management Platform for Genomics
Malachi Griffith et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
False Discovery Rates for Rare Variants From Sequenced Data
Marinela Capanu et al.
GENETIC EPIDEMIOLOGY (2015)
Chromosomal Instability Selects Gene Copy-Number Variants Encoding Core Regulators of Proliferation in ER+ Breast Cancer
David Endesfelder et al.
CANCER RESEARCH (2014)
Standardized decision support in next generation sequencing reports of somatic cancer variants
Rodrigo Dienstmann et al.
MOLECULAR ONCOLOGY (2014)
Prognostic significance of FOXP3+tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration
Shuzhen Liu et al.
BREAST CANCER RESEARCH (2014)
Oncogenic ERBB3 Mutations in Human Cancers
Bijay S. Jaiswal et al.
CANCER CELL (2013)
DNA-Mutation Inventory to Refine and Enhance Cancer Treatment (DIRECT): A Catalog of Clinically Relevant Cancer Mutations to Enable Genome-Directed Anticancer Therapy
Paul Yeh et al.
CLINICAL CANCER RESEARCH (2013)
Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants
Wenqing Fu et al.
NATURE (2013)
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
Weiyi Toy et al.
NATURE GENETICS (2013)
DGIdb: mining the druggable genome
Malachi Griffith et al.
NATURE METHODS (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer
Ron Bose et al.
CANCER DISCOVERY (2013)
Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
Shunqiang Li et al.
CELL REPORTS (2013)
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Marcin Imielinski et al.
CELL (2012)
A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen
Stephen K. Chia et al.
CLINICAL CANCER RESEARCH (2012)
Cancer chromosomal instability: therapeutic and diagnostic challenges
Nicholas McGranahan et al.
EMBO REPORTS (2012)
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
Daniel C. Koboldt et al.
GENOME RESEARCH (2012)
The landscape of cancer genes and mutational processes in breast cancer
Philip J. Stephens et al.
NATURE (2012)
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
Sohrab P. Shah et al.
NATURE (2012)
Whole-genome analysis informs breast cancer response to aromatase inhibition
Matthew J. Ellis et al.
NATURE (2012)
Sequence analysis of mutations and translocations across breast cancer subtypes
Shantanu Banerji et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen
Ana M. Mendes-Pereira et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
LOVD v.2.0: The Next Generation in Gene Variant Databases
Ivo F. A. C. Fokkema et al.
HUMAN MUTATION (2011)
DDR1 triggers epithelial cell differentiation by promoting cell adhesion through stabilization of E-cadherin
Yi-Chun Yeh et al.
MOLECULAR BIOLOGY OF THE CELL (2011)
A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada-Clinical Trials Group Trial, MA.12)
V. H. C. Bramwell et al.
ANNALS OF ONCOLOGY (2010)
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
Torsten O. Nielsen et al.
CLINICAL CANCER RESEARCH (2010)
Diverse somatic mutation patterns and pathway alterations in human cancers
Zhengyan Kan et al.
NATURE (2010)
A map of human genome variation from population-scale sequencing
David Altshuler et al.
NATURE (2010)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Maggie C. U. Cheang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia
Marc M. Loriaux et al.
BLOOD (2008)
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding et al.
NATURE (2008)
Size, power and false discovery rates
Bradley Efron
ANNALS OF STATISTICS (2007)
Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas
Stephen J. Chanock et al.
BREAST CANCER RESEARCH (2007)
Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen
H. F. Kennecke et al.
ANNALS OF ONCOLOGY (2007)
Deficiency in the catalytic subunit of DNA-Dependent protein kinase causes down-regulation of ATM
YL Peng et al.
CANCER RESEARCH (2005)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
Altered affinity of CBFβ-SMMHC for Runx1 explains its role in leukemogenesis
SM Lukasik et al.
NATURE STRUCTURAL BIOLOGY (2002)
Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development
WF Vogel et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
分享论文
